Logos Global Management’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.1M | Buy |
|
|||||
|
2025
Q1 | $5.23M | Buy |
|
|||||
|
2024
Q4 | $10.6M | Buy |
|
|||||
|
2024
Q3 | $5.75M | Sell |
|
|||||
|
2024
Q2 | $9.35M | Sell |
|
|||||
|
2024
Q1 | $49.1M | Sell |
|
|||||
|
2023
Q4 | $25M | Sell |
|
|||||
|
2023
Q3 | $19.5M | Buy |
|
|||||
|
2023
Q2 | $20M | Buy |
|
|||||
|
2023
Q1 | $19.6M | Sell |
|
|||||
|
2022
Q4 | $24.9M | Sell |
|
|||||
|
2022
Q3 | $29M | Sell |
|
|||||
|
2022
Q2 | $19.9M | Buy |
|
|||||
|
2022
Q1 | $26.4M | Sell |
|
|||||
|
2021
Q4 | $38.5M | Sell |
|
|||||
|
2021
Q3 | $58.8M | Buy |
|
|||||
|
2021
Q2 | $43.2M | Sell |
|
|||||
|
2021
Q1 | $49.8M | Buy |
|
|||||
|
2020
Q4 | $33.7M | Hold |
|
|||||
|
2020
Q3 | $32.4M | Buy |
|